Re: Factors affecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG.
作者信息
Huang Haichao, Jin Jie, Li Xin
机构信息
Haichao Huang, Department of Urology,Peking University First Hospital and Institute of Urology, Peking University, National Urological Cancer Center, 8 Xishiku Street, Xicheng District, Beijing 100034, China.
Jie Jin, Department of Urology,Peking University First Hospital and Institute of Urology, Peking University, National Urological Cancer Center, 8 Xishiku Street, Xicheng District, Beijing 100034, China.
出版信息
Pak J Med Sci. 2014 Nov-Dec;30(6):1432. doi: 10.12669/pjms.306.6408.
Abstract
摘要
相似文献
1
Re: Factors affecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG.关于：影响经膀胱内卡介苗治疗的高级别非侵袭性膀胱癌复发和进展的因素
Pak J Med Sci. 2014 Nov-Dec;30(6):1432. doi: 10.12669/pjms.306.6408.
2
Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.对于高级别非肌层浸润性膀胱癌，在膀胱内灌注卡介苗后进行抗炎治疗可能不会对肿瘤学结局产生负面影响。
World J Urol. 2017 Jan;35(1):105-111. doi: 10.1007/s00345-016-1853-z. Epub 2016 May 18.
3
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.使用复发性肿瘤分级来指导卡介苗治疗：低级别复发并非良性。
Eur Urol Oncol. 2019 May;2(3):286-293. doi: 10.1016/j.euo.2018.08.013. Epub 2018 Sep 10.
4
[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]
Hinyokika Kiyo. 2004 Nov;50(11):767-71.
5
6
Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer.经尿道卡介苗免疫治疗用于治疗先前行前列腺放疗的高级别非肌肉浸润性膀胱癌。
Urol Oncol. 2013 Aug;31(6):857-61. doi: 10.1016/j.urolonc.2011.07.005. Epub 2011 Aug 24.
7
Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后膀胱内卡介苗治疗后续非肌层浸润性膀胱癌的结果。
BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.
9
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.CG0070溶瘤病毒方案治疗卡介苗无反应性非肌层浸润性膀胱癌患者安全性和有效性的开放标签、单臂、II期多中心研究：中期结果
Urol Oncol. 2018 Oct;36(10):440-447. doi: 10.1016/j.urolonc.2017.07.005. Epub 2017 Jul 26.
10
Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer.免疫功能低下的膀胱癌患者膀胱内卡介苗。
BJU Int. 2013 May;111(6):984-7. doi: 10.1111/j.1464-410X.2012.11778.x. Epub 2013 Jan 25.
本文引用的文献
1
Factors effecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG.影响经膀胱内卡介苗治疗的高级别非浸润性膀胱癌复发和进展的因素。
Pak J Med Sci. 2014 Mar;30(2):326-30. doi: 10.12669/pjms.302.4117.
Zotero 插件